Aspartate availability drives differential engagement of the malate-aspartate shuttle

Julia S. Brunner(Memorial Sloan Kettering Cancer Center), Lydia W.S. Finley(Memorial Sloan Kettering Cancer Center)

Molecular Cell

February 26, 2026

10.1016/j.molcel.2026.02.004

Cited by 1

Related Papers

A metabolic prosurvival role for PML in breast cancer

|Journal of Clinical Investigation|2012|272